ASND — Ascendis Pharma A/S stock price, charts and financials

QT55Ascendis Pharma A/S

Ascendis Pharma A/S (NASDAQ: ASND) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
244.59
+1.14+0.47%
OverviewShort InterestFilings
ASNDQT55Ascendis Pharma A/S·NASDAQ
244.59+0.47%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 15, 20266-KForeign issuer report
Jun 30, 20266-KForeign issuer report
Jun 29, 20266-KForeign issuer report
Jun 17, 20266-KForeign issuer report
Jun 15, 20266-KForeign issuer report
Jun 12, 20266-KForeign issuer report
Jun 10, 20266-KForeign issuer report
Jun 02, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20263/AInitial statement of beneficial ownership (amended)
Jun 01, 20264Statement of changes in beneficial ownership
May 27, 20264Statement of changes in beneficial ownership
May 22, 2026SDSpecialized disclosure report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 13, 20266-KForeign issuer report
May 12, 20264Statement of changes in beneficial ownership
May 07, 20266-KForeign issuer report
May 07, 20266-KForeign issuer report
May 07, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 07, 2026SC 13GBeneficial ownership statement (passive)
May 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 21, 20266-KForeign issuer report
Apr 21, 20266-KForeign issuer report
Apr 20, 20268-A12B/A8-A12B/A
#1 / 25 of 316
Page
▼
/ 13